SEARCH

SEARCH BY CITATION

References

  • Ackerman CM, Lowe LP, Lee H., Chen F., Hughes E., Cholod P., Dyer AR, Hayes MG, Metzger BE, Lowe WL, Urbanek M.. The role of the polycystic ovary syndrome susceptibility locus D19S884 allele 8 in maternal glycemia and fetal size. J Clin Endocrinol Metab. 2010; 95: 32423250.
  • Beilin J., Ball EM, Favaloro JM, Zajac JD. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol. 2000; 25: 8596.
  • Benn-Torres J., Bonilla C., Robbins CM, Waterman L., Moses TY, Hernandez W., Santos ER, Bennett F., Aiken W., Tullock T., Coard K., Hennis A., Wu S., Nemesure B., Leske MC, Freeman V., Carpten J., Kittles RA. Admixture and population stratification in African Caribbean populations. Ann Hum Genet. 2008; 72: 9098.
  • Buchanan G., Yang M., Cheong A., Harris JM, Irvine RA, Lambert PF, Moore NL, Raynor M., Neufing PJ, Coetzee GA, Tilley WD. Structural and functional consequences of glutamine tract variation in the androgen receptor. Hum Mol Genet. 2004; 13: 16771692.
  • Chambers JC, Zhang W., Zabaneh D., Sehmi J., Jain P., McCarthy MI, Froguel P., Ruokonen A., Balding D., Jarvelin MR, Scott J., Elliott P., Kooner JS. Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians. Diabetes. 2009; 58: 27032708.
  • Chatterjee S., Singh R., Kadam S., Maitra A., Thangaraj K., Meherji P., Modi D.. Longer CAG repeat length in the androgen receptor gene is associated with premature ovarian failure. Hum Reprod. 2009; 24: 32303235.
  • Edwards A., Hammond HA, Jin L., Caskey CT, Chakraborty R.. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics. 1992; 12: 241253.
  • Gelmann EP. Molecular biology of the androgen receptor. J Clin Oncol. 2002; 20: 30013015.
  • HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes. 2009; 58: 453459.
  • HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U., Coustan DR, Hadden DR, McCance DR, Hod M., McIntyre HD, Oats JJ, Persson B., Rogers MS, Sacks DA. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358: 19912002.
  • Harada N., Mitani T., Higashimura Y., Yamaji R., Okamoto K., Nakano Y., Inui H.. Involvement of three glutamine tracts in human androgen receptor transactivation. J Steroid Biochem Mol Biol. 2010; 118: 7784.
  • Katsuno M., Adachi H., Waza M., Banno H., Suzuki K., Tanaka F., Doyu M., Sobue G.. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA). Exp Neurol. 2006; 200: 818.
  • Katzenellenbogen JA, Katzenellenbogen BS. Nuclear hormone receptors: ligand-activated regulators of transcription and diverse cell responses. Chem Biol. 1996; 3: 529536.
  • Ludwig AH, Murawska M., Panek G., Timorek A., Kupryjanczyk J.. Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome. Endocr Relat Cancer. 2009; 16: 10051016.
  • Lund A., Udd B., Juvonen V., Andersen PM, Cederquist K., Davis M., Gellera C., Kolmel C., Ronnevi LO, Sperfeld AD, Sorensen SA, Tranebjaerg L., Van Maldergem L., Watanabe M., Weber M., Yeung L., Savontaus ML. Multiple founder effects in spinal and bulbar muscular atrophy (SBMA, Kennedy disease) around the world. Eur J Hum Genet. 2001; 9: 431436.
  • Mariotti C., Castellotti B., Pareyson D., Testa D., Eoli M., Antozzi C., Silani V., Marconi R., Tezzon F., Siciliano G., Marchini C., Gellera C., Donato SD. Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul Disord. 2000; 10: 391397.
  • McPhaul MJ, Marcelli M., Tilley WD, Griffin JE, Isidro-Gutierrez RF, Wilson JD. Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. J Clin Invest. 1991; 87: 14131421.
  • Mohlig M., Jurgens A., Spranger J., Hoffmann K., Weickert MO, Schlosser HW, Schill T., Brabant G., Schuring A., Pfeiffer AF, Gromoll J., Schofl C.. The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome. Eur J Endocrinol. 2006; 155: 127130.
  • NHANES. NHANES III Reference Manuals and Reports. Analytic and Reporting Guidelines: The Third National Health and Nutrition Examination Survey (1988–94) [CD-ROM]. Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention; 1997.
  • Palazzolo I., Gliozzi A., Rusmini P., Sau D., Crippa V., Simonini F., Onesto E., Bolzoni E., Poletti A.. The role of the polyglutamine tract in androgen receptor. J Steroid Biochem Mol Biol. 2008; 108: 245253.
  • Rahman F., Christian HC. Non-classical actions of testosterone: an update. Trends Endocrinol Metab. 2007; 18: 371378.
  • Rousset F.. Genepop'007: a complete reimplementation of the Genepop software for Windows and Linux. Mol Ecol Resour. 2008; 103106.
  • Rousset F., Raymond M.. Testing heterozygote excess and deficiency. Genetics. 1995; 140: 14131419.
  • Shaik NA, Govindan S., Kodati V., Rao KP, Hasan Q.. Polymorphic (CAG)n repeats in the androgen receptor gene: a risk marker for endometriosis and uterine leiomyomas. Hematol Oncol Stem Cell Ther. 2009; 2: 289293.
  • Stanworth RD, Kapoor D., Channer KS, Jones TH. Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes. Eur J Endocrinol. 2008; 159: 739746.
  • Tan JT, Ng DP, Nurbaya S., Ye S., Lim XL, Leong H., Seet LT, Siew WF, Kon W., Wong TY, Saw SM, Aung T., Chia KS, Lee J., Chew SK, Seielstad M., Tai ES. Polymorphisms identified through genome-wide association studies and their associations with type 2 diabetes in Chinese, Malays, and Asian-Indians in Singapore. J Clin Endocrinol Metab. 2010; 95: 390397.
  • Wu MH, Chou YC, Yu CP, Yang T., You SL, Chen CJ, Sun CA. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility. Eur J Cancer Prev. 2008; 17: 317322.
  • Zitzmann M., Gromoll J., von Eckardstein A., Nieschlag E.. The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia. 2003; 46: 3139.